Hercules Capital Management

Management criteria checks 2/4

Hercules Capital's CEO is Scott Bluestein, appointed in Apr 2014, has a tenure of 10.58 years. total yearly compensation is $8.89M, comprised of 7.3% salary and 92.7% bonuses, including company stock and options. directly owns 1.34% of the company’s shares, worth $40.82M. The average tenure of the management team and the board of directors is 5.8 years and 4.3 years respectively.

Key information

Scott Bluestein

Chief executive officer

US$8.9m

Total compensation

CEO salary percentage7.3%
CEO tenure10.6yrs
CEO ownership1.3%
Management average tenure5.8yrs
Board average tenure4.3yrs

Recent management updates

Recent updates

Hercules Capital: This 10% Yield Is Rock Solid

Nov 19

Hercules Capital At 70% Premium, Or The Simple High-Yield ETF HYG At NAV?

Nov 05

Earnings Miss: Hercules Capital, Inc. Missed EPS By 18% And Analysts Are Revising Their Forecasts

Nov 01
Earnings Miss: Hercules Capital, Inc. Missed EPS By 18% And Analysts Are Revising Their Forecasts

Hercules Capital (NYSE:HTGC) Has Affirmed Its Dividend Of $0.48

Oct 31
Hercules Capital (NYSE:HTGC) Has Affirmed Its Dividend Of $0.48

Hercules Capital: The Valuation Is My Only Concern

Oct 22

Hercules Capital: How Good Is This 10% Yield?

Oct 15

Hercules Capital: The Yield And Underlying Value Remain Attractive

Sep 13

Hercules Capital: This 10% Yield Is On Sale (Rating Upgrade)

Aug 26

Hercules Capital BDC: 10% Yield, Record Earnings

Aug 09

Hercules Capital (NYSE:HTGC) Is Paying Out A Dividend Of $0.48

Aug 02
Hercules Capital (NYSE:HTGC) Is Paying Out A Dividend Of $0.48

Hercules Capital: Recent Improvements But Currently Very Expensive

Jul 22

Hercules Capital: 2 Possible Outcomes (Rating Downgrade)

Jul 08

Hercules Capital: A Solid Dividend Stock But Valuation Concerns Are Valid

Jun 25

Hercules Capital: A Premium Company, But Better To Wait Until Interest Rates Decrease

Jun 07

Hercules Capital: Solid 10% Yield, But Sky-High Valuation

May 10

Hercules Capital: VC-Focused Name With Less Risk And Better Return Prospects Than Average BDC

May 04

Hercules Capital: Winning Option In The Financial Services Space

Apr 24

There Is A Reason Hercules Capital, Inc.'s (NYSE:HTGC) Price Is Undemanding

Apr 22
There Is A Reason Hercules Capital, Inc.'s (NYSE:HTGC) Price Is Undemanding

Hercules Capital: Record Year In 2023, 10% Yield

Mar 29

Unlocking Hercules Capital's Income Potential: A Fresh Look At Dividend Timing Strategies

Feb 23

Results: Hercules Capital, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

Feb 18
Results: Hercules Capital, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

Hercules Capital: Still Resilient With Solid Prospects Despite The VC Focus

Feb 17

Hercules Capital: A Different Type Of VC-Focused BDC

Jan 16

Hercules Capital Poised For Potential Market Surge In 2024

Dec 24

Lacklustre Performance Is Driving Hercules Capital, Inc.'s (NYSE:HTGC) Low P/E

Dec 18
Lacklustre Performance Is Driving Hercules Capital, Inc.'s (NYSE:HTGC) Low P/E

10%-Yielding Hercules Capital: Better Ingredients, Better Outcomes

Dec 15

Main Street Capital Vs. Hercules Capital: Why Choose?

Nov 22

Hercules Capital: 10% Yield, My Largest BDC Position

Nov 13

10%-Yielding Hercules Capital Is A BDC Superstar

Oct 10

Hercules Capital: Venture Capital Financier Offering High Yield And Robust Balance Sheet

Sep 17

Hercules Capital: 10% Yield, Strong Coverage, Low Leverage

Sep 09

Let's Build A Bond Portfolio Together: Hercules Capital Bonds 2026 7.10%

Aug 15

Hercules Capital: Fatter Yield, Surging Stock Price

Aug 05

Hercules Capital: The Tide Is Turning - Buy While It's Cheap (Rating Upgrade)

Jun 28

Hercules Capital raises dividend by 8.3% to $0.39/share, supplemental cash distribution of $0.08

Feb 14

Hercules Capital: 2 Top Reasons To Buy This 10.1%-Yielding BDC

Jan 25

Should You Buy Hercules Capital Before Or After Its Ex-Dividend Date?

Jan 11

Hercules Capital: Bear Market Rally Fizzling Out

Dec 08

Oak Street Health secures $300M in financing

Nov 16

CEO Compensation Analysis

How has Scott Bluestein's remuneration changed compared to Hercules Capital's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

US$318m

Jun 30 2024n/an/a

US$278m

Mar 31 2024n/an/a

US$331m

Dec 31 2023US$9mUS$650k

US$334m

Sep 30 2023n/an/a

US$277m

Jun 30 2023n/an/a

US$302m

Mar 31 2023n/an/a

US$197m

Dec 31 2022US$7mUS$650k

US$100m

Sep 30 2022n/an/a

US$42m

Jun 30 2022n/an/a

US$12m

Mar 31 2022n/an/a

US$105m

Dec 31 2021US$6mUS$650k

US$172m

Sep 30 2021n/an/a

US$319m

Jun 30 2021n/an/a

US$339m

Mar 31 2021n/an/a

US$318m

Dec 31 2020US$7mUS$650k

US$226m

Sep 30 2020n/an/a

US$120m

Jun 30 2020n/an/a

US$96m

Mar 31 2020n/an/a

US$83m

Dec 31 2019US$8mUS$594k

US$173m

Sep 30 2019n/an/a

US$111m

Jun 30 2019n/an/a

US$128m

Mar 31 2019n/an/a

US$132m

Dec 31 2018US$11mUS$515k

US$76m

Sep 30 2018n/an/a

US$111m

Jun 30 2018n/an/a

US$109m

Mar 31 2018n/an/a

US$90m

Dec 31 2017US$3mUS$500k

US$78m

Compensation vs Market: Scott's total compensation ($USD8.89M) is above average for companies of similar size in the US market ($USD6.63M).

Compensation vs Earnings: Scott's compensation has increased by more than 20% in the past year.


CEO

Scott Bluestein (46 yo)

10.6yrs

Tenure

US$8,891,994

Compensation

Mr. Scott Bluestein is Miscellaneous of UBS Securities LLC. He is Chief Executive Officer, Chief Investment Officer, President and Director of Hercules Capital, Inc. He joined the Hercules Capital, Inc. in...


Leadership Team

NamePositionTenureCompensationOwnership
Scott Bluestein
CEO, Chief Investment Officer10.6yrsUS$8.89m1.34%
$ 40.8m
Seth Meyer
CFO & Chief Accounting Officer5.7yrsUS$3.04m0.21%
$ 6.4m
Christian Follmann
Chief Operating Officer8.8yrsUS$1.21m0.059%
$ 1.8m
Kiersten Botelho
Corporate Secretary2.8yrsUS$1.08m0.029%
$ 896.8k
Steve Kuo
Senior MD & Group Head of Technology5.8yrsno datano data
Michael Hara
Managing Director of Investor Relations & Corporate Communicationsno datano datano data
Kate Kinlin
VP of Human Resources2.6yrsno datano data
Roy Liu
Managing Director20.6yrsno datano data
R. Jadot
Senior MD & Group Head of Life Sciences5.5yrsno datano data
Michael Bowden
Managing Director of Portfolio Management5.8yrsno datano data
Janice Bourque
Managing Director14.6yrsno datano data
Lesya Kulchenko
Managing Director5.8yrsno datano data

5.8yrs

Average Tenure

52yo

Average Age

Experienced Management: HTGC's management team is seasoned and experienced (5.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Scott Bluestein
CEO, Chief Investment Officer5.3yrsUS$8.89m1.34%
$ 40.8m
Gayle Crowell
Independent Director5.8yrsUS$215.00k0.037%
$ 1.1m
Robert Badavas
Chairman of the Board & Lead Independent Director18.7yrsUS$310.00k0.070%
$ 2.1m
Pam Randhawa
Independent Director3yrsUS$250.00k0.010%
$ 304.7k
Nikos Theodosopoulos
Independent Director1.2yrsUS$39.99k0.0035%
$ 107.0k
Thomas Fallon
Independent Director10.3yrsUS$205.00k0.062%
$ 1.9m
Wade Loo
Independent Director3.3yrsUS$215.00k0.017%
$ 504.6k
DeAnne Aguirre
Independent Board Directors2.4yrsUS$145.00k0.0086%
$ 262.2k

4.3yrs

Average Tenure

62.5yo

Average Age

Experienced Board: HTGC's board of directors are considered experienced (4.3 years average tenure).